|
FY2025
12 months to Dec 31, 2025
|
FY2024
6 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Payment of general and administrative costs through IPO Promissory Note | ||
| Interest earned on investments in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Reimbursement receivable | ||
| Prepaid expenses and insurance | ||
| Long Term prepaid insurance | ||
| Accrued expenses | ||
| Accrued offering costs | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Private placement warrants | ||
| Payments of offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Non-cash financing activities: | ||
| Offering costs included in accrued offering costs | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B Ordinary Shares | ||
| Deferred offering costs paid through IPO Promissory Note - related party | ||
| Prepaid expenses paid through IPO Promissory Note - related party | ||
| Deferred Fee payable |
Loading...
